PMAQX | PMVAX | PMAQX / PMVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 8 years | 25 years | - |
Gain YTD | 2.173 | 4.760 | 46% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 29.3B | 428M | 6,846% |
Annual Yield % from dividends | 0.10 | 0.00 | - |
Returns for 1 year | 19.96 | 8.40 | 238% |
Returns for 3 years | 20.53 | 4.13 | 497% |
Returns for 5 years | 41.71 | 10.40 | 401% |
Returns for 10 years | N/A | 13.44 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
IVFLX | 3.68 | 0.02 | +0.55% |
Federated Hermes Intl Strat Val Div R6 | |||
LIFLX | 14.20 | 0.07 | +0.50% |
Lord Abbett Focused Large Cap Value I | |||
TQAAX | 43.78 | 0.18 | +0.41% |
T. Rowe Price Integrated US Sm Gr Eq Adv | |||
GGFPX | 14.12 | 0.05 | +0.36% |
Goldman Sachs Intl Eq Insghts P | |||
MYINX | 7.66 | 0.01 | +0.13% |
NYLI WMC International Rsrch Eq Inv Cl |